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Abstract
Introduction: Nearly 40 years into the HIV epidemic, the persistence of HIV stigma is a matter of grave urgency. Discrimina-
tion (i.e. enacted stigma) in healthcare settings is particularly problematic as it deprives people of critical healthcare services
while also discouraging preventive care seeking by confirming fears of anticipated stigma. We review existing research on the
effectiveness of stigma interventions in healthcare settings of low- and middle-income countries (LMIC), where stigma control
efforts are often further complicated by heavy HIV burdens, less developed healthcare systems, and the layering of HIV
stigma with discrimination towards other marginalized identities. This review describes progress in this field to date and identi-
fies research gaps to guide future directions for research.
Methods: We conducted a scoping review of HIV reduction interventions in LMIC healthcare settings using Embase, Ovid
MEDLINE, PsycINFO and Scopus (through March 5, 2020). Information regarding study design, stigma measurement tech-
niques, intervention features and study findings were extracted. We also assessed methodological rigor using the Joanna
Briggs Institute checklist for systematic reviews.
Results and discussion: Our search identified 8766 studies, of which 19 were included in the final analysis. All but one study
reported reductions in stigma following the intervention. The studies demonstrated broad regional distribution across LMIC
and many employed designs that made use of a control condition. However, these strengths masked key shortcomings includ-
ing a dearth of research from the lowest income category of LMIC and a lack of interventions to address institutional or struc-
tural determinants of stigma. Lastly, despite the fact that most stigma measures were based on existing instruments, only
three studies described steps taken to validate or adapt the stigma measures to local settings.
Conclusions: Combating healthcare stigma in LMIC demands interventions that can simultaneously address resource con-
straints, high HIV burden and more severe stigma. Our findings suggest that this will require more objective, reliable and cul-
turally adaptable stigma measures to facilitate meaningful programme evaluation and comparison across studies. All but one
study concluded that their interventions were effective in reducing healthcare stigma. Though encouraging, the fact that most
studies measured impact using self-reported measures suggests that social desirability may bias results upwards. Homogeneity
of study results also hindered our ability to draw substantive conclusions about potential best practices to guide the design of
future stigma reduction programmes.
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1 | INTRODUCTION
Despite tremendous biomedical advances to make HIV more
preventable [1-3] and more treatable [4], stigma is still cited
as a significant barrier to controlling the epidemic. Stigma is
defined as the social devaluation of a person based on an
attribute [5], and discrimination is often described as the end
result of stigmatization [6]. HIV stigma that unfolds in
healthcare settings can be particularly harmful as it directly
impacts public health outcomes. For example stigma by provi-
ders can result in service refusal, failure to offer HIV services,
or negative clinical experiences that discourage future care
seeking for those in need of services [7-9]. Among people liv-
ing with HIV (PLWH), experiences of healthcare stigma have
been associated with more adverse mental health outcomes
[10,11], poorer healthcare access [12-14] and more rapid
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disease progression [15,16]. PLWH experiences of enacted
healthcare stigma are widely documented across the
globe.[17-19] Large-scale stigma reduction efforts will need to
be a cornerstone of planned global efforts to end the AIDS
epidemic by 2030 [20].
Researchers have traditionally divided stigma into internal-
ized, enacted, anticipated and perceived stigma. Internalized
stigma or “self-stigma” occurs when targets of stigma internal-
ize the negative attitudes and perceptions projected onto
them [21]. Enacted stigma refers to overt acts of discrimina-
tion and hostility directed at those perceived to have the stig-
matized status, and anticipated stigma result from fear of
enacted stigma [22]. Lastly perceived stigma pertains to how
PLWH perceive their partners, friends, family and community
to treat and view HIV and PLWH in general [6]. The various
forms of stigma are often cyclical [23]: for example PLWH fac-
ing enacted stigma may be denied critical health services
which may in turn validate their fears of anticipated stigma or
expose them to negative experiences that deepen internalized
stigma [21]. Interrupting stigma will therefore require inter-
ventions at multiple points in the cycle. Its inherently social
nature will also require multi-level interventions that target
not only individual-level behaviours but also change at the
interpersonal, social, organizational and societal levels [24].
A rich history of HIV stigma interventions has been docu-
mented in four known reviews to date [25-28]. Most employ
a narrative approach to highlight the positive intervention
effects reported by the majority of included studies, while also
pointing out that these gains mask shortcomings in terms of
short duration of effects [26], lack of methodological rigor
[25] and inconsistent measures used across studies [28]. The
fourth review, the only meta-analysis, quantifies a significant
but small effect across included studies to arrive at a similar
conclusion regarding issues with study quality [27]. These four
reviews are broadly inclusive of all studies on HIV stigma
interventions regardless of the target population, intervention
setting and global region. But their analyses do not focus on
healthcare settings, the individuals who work in these settings,
or on high priority regions.
This scoping review aims to expand on past reviews by
assessing the design and impact of stigma reduction interven-
tions conducted in healthcare settings of low- and middle-in-
come countries (LMIC). It also examines the methodological
quality of these studies with particular attention to how
stigma was measured. We opted to conduct a scoping
approach (as opposed to other approaches such as a system-
atic review) in order to characterize the nature of evidence
for these stigma interventions [29]. The substantial hetero-
geneity in approaches to measuring stigma and the interven-
tions for reducing it presented challenges in specifying a
clearly defined question (e.g. “does this strategy effectively
reduce this specific outcome?”) also made a scoping review
the more practical choice [30]. We focus on healthcare stigma
in LMIC because of the unique combination of factors that
shape stigma in these settings such as heavier HIV burden
[31,32], less developed primary healthcare systems [33,34],
and the layering of HIV stigma with discrimination towards
other marginalized identities such as sexual minorities [35],
commercial sex workers [36] or people who inject drugs [37].
In such settings, pursuit of global “best practices” for combat-
ing stigma can miss opportunities inadvertently results in the
direct importation of western-style interventions. By investi-
gating studies in LMIC where the inherent challenges of
stigma reduction are further compounded by resource con-
straints and other limitations, this review describes progress
to date in the control of stigma in settings where these pro-
grammes may have the greatest impact.
2 | METHODS
The Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) Guidelines were followed to conduct
the review and analysis [30].
2.1 | Search strategy
A public health librarian (author SLH) created the literature
search strategy after meeting with two members of the
research team to clarify goals and further define selection cri-
teria. The search strategy was built and tested for sensitivity
in Embase using Emtree subject headings and keywords, and
the search strategy was translated to three other databases:
Ovid MEDLINE, PsycINFO and Scopus. There were no lan-
guage or time restrictions placed on the search, which was
conducted on 29 to 30 November 2018. Several additional
texts were added in the course of revisions up through 5
March 2019.
Four conceptual domains were used to build the list of rele-
vant search terms: health outcome (i.e. HIV), region (i.e.
LMIC), key topic area (i.e. stigma in healthcare settings) and
study design (i.e. intervention). Terms selected for each
domain to include widely used language, acronyms and phras-
ings common in the medical and health sciences literature.
Search terms defining the regional scope of the paper
included a list of the 164 countries defined as low, low-middle
and upper-middle income by the World Bank [38], as well as
inclusion of a set of search terms commonly used to describe
LMIC published by the Health Sciences Library at the Univer-
sity of North Carolina [39]. Terminology related to stigma and
interventions were tested and reduced down to the terms in
the Appendix S1 to reduce the sensitivity and increase the
specificity of the search. Lastly, we screened the reference
lists of selected articles to locate other potentially relevant
studies and scanned the Internet for relevant grey literature
including non-peer-reviewed reports or documents. Specific
search terms used in the Embase search strategy are pro-
vided in the Appendix S1.
2.2 | Study selection
Authors MKS and RHX reviewed the resulting titles and
abstracts to identify articles that: (1) specified reduction in
HIV-related stigma in healthcare settings as at least one of
the study aims, (2) included healthcare workers as members
of the population targeted by the intervention and (3) took
place in an LMIC as defined in the previous section. Note that
while our topical interest centred on enacted stigma, we
applied this criteria liberally in order to include studies that
described issues of stigma in the context of patient-provider
encounters, regardless of whether the authors explicitly used
the term “enacted stigma.” We defined healthcare workers as
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professionally trained medical personnel such as doctors,
nurses, physician’s assistants, pharmacists, but not situationally
trained lay workers such as community health workers or vol-
unteer support staff. We drew this distinction because profes-
sional healthcare workers hold disproportionate power over
their patients by way of their authority to prescribe (or with-
hold) life-saving drugs, to perform (or abstain from) necessary
medical procedures, or to refer patients to other medical spe-
cialists. Though practice around the inclusion of conference
abstracts in scoping reviews vary, our team opted to include
them in order to address the publication bias that tends to
favour more frequent and more rapid publication of reports
with positive results [40].
Next, the same two authors conducted a full-text review to
further determine its appropriateness for inclusion in the final
analysis. In cases where multiple articles described the same
intervention, only the reference with the most complete infor-
mation was retained. All aspects of the review and text screen-
ing were carried out by authors MKS and RX independently in
the software program Rayyan [41]. Discrepancies in decisions
regarding article inclusion were resolved through discussion.
Figure 1 shows the flow diagram for study selection.
2.3 | Data extraction and bias assessment
Author MKS created an initial draft of a data extraction chart
containing study features of interest a priori. Authors MKS and
RHX then assessed chart utility by conducting data extraction for
the first five articles, after which they compared results and
amended the chart to better reflect study features and charac-
teristics relevant to the analysis. A full data extraction was then
carried out independently on each article by MKS and RHX, who
met for a final time to resolve any differences in classifications.
The following data were extracted: study region, specific
target population, sample size, study design, type of stigma
measure, intervention characteristics and primary results.
Approaches for stigma measurement were categorized into
the three domains as identified by Nyblade et al. [42] and
included providers’ awareness about the negative impacts of
stigma, their knowledge about HIV transmission as it relates
to fear of occupational exposure, moral or value-based associ-
ations they have of HIV with socially taboo behaviours, and
enacted stigma (i.e. actual measures of discriminatory beha-
viours on the part of providers).
Interventions were then categorized in three ways. First we
determined the levels at which changes were sought: individual-
level strategies such as improving provider awareness of stigma
versus institutional-level changes such as implementation of
guidelines for universal precautions. Second, we classified inter-
ventions using the four intervention types defined by Brown
et al. [26]: information-based training, skills building, contact with
affected groups such as PLWH, and institutional changes such as
altering clinic policy around PLWH care (e.g. ending the practice
of segregating inpatients by HIV status). Last, we conducted a
risk of bias assessment for all studies in the final sample set using
the Joanna Briggs Institute checklist for systematic reviews [43].
Checklists specific to randomized control trials (RCT) and quasi-
experimental studies were applied separately to studies of corre-
sponding design. Responses to each criteria were assessed using
“yes” if criteria were met, “no” if they were not met, “N/A” if the
question did not apply to the particular study, and “unclear” if the
information could not be determined from the available text. We
then assigned a final “overall rating” to each study based on the
following algorithm: studies failing to meet more than two criteria
were classified as “poor,” those that failed to meet exactly two cri-
teria as “fair,” and less than two as “good.” Criteria classified as
“N/A” or “unclear” were treated as equivalent to half of a “no;” for
example a study whose criteria rating included a single “no” and
two “unclears” would receive an overall rating of “fair.”
3 | RESULTS AND DISCUSSION
The initial search produced 8766 results (Embase = 2605;
Ovid Medline = 2215; PsycINFO = 1089; Scopus = 2857),
and after removing duplicates, 4369 studies remained. Review
Figure 1. Flow diagram for study selection.
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of the titles and abstracts identified 80 studies for full-text
examination, after which 19 studies were found to meet crite-
ria regarding the outcome of interest (enacted healthcare
stigma), the study population (healthcare workers) and study
design (intervention; Figure 1). Most of the studies were pub-
lished as full articles in peer reviewed journals [44-57], with
the remainder published as conference abstracts [58-60] or
public reports [61-63] (Table 1).
According to the World Bank geoscheme [89], a third of
studies were located in sub-Saharan Africa
[45,48,57,59,61,63,83] followed by South Asia
[44,54,55,58,60,62]. Among the 10 studies located in East
Asia and the Pacific, six took place in China and India which
account for over half of people living with HIV in the region
[50-52,75]. Only one study was conducted in the Middle East
and Northern Africa [53] (Figure 2). Additionally, two studies
had sites in multiple countries, most of which were collectively
located in sub-Saharan Africa [47], but one of which also had
a single site in Latin American and the Caribbean [56]. The
most common study design was a single group pre/post-test
comparison [44,45,47,51,52,54,57,59,60,62,63] followed by
pre/post-test comparisons with a control group
[46,49,55,56,58,61,63] (including one that used a comparative
effectiveness trial design [49]) and RCTs [48,50,75].
3.1 | Intervention strategies and impact
Interventions conducted by every study in this review focused
on the individual-level changes which included strategies such
as improvement of HIV knowledge or reduction in discrimina-
tory attitudes. Among these, six studies [44,50,59,60,62,63]
additionally included strategies focused on institutional-level
change, such as implementation of universal precautions, pro-
vision of preventive medical equipment like gloves or sharps
containers and reversal of discriminatory clinical practices
such as marking patient medical records to signal their HIV
status to colleagues.
Using the classification strategy introduced by Brown et al.,
every study in this review was found to have employed at
least two strategies as part of the intervention, with some
using three [53,54,75] or at most four [59,62] approaches in
the same study. Information-based training was included in
every study, an approach most commonly deployed through
didactic lectures or group discussion. Skills-building was used
in all but three of the studies [47,55,60] and involved tech-
niques such as role playing, group brainstorming or sharing of
personal experiences. Contact with affected groups was used
in less than half [47,53-55,58,59,62,75] of studies, and institu-
tional changes such as desegregation of patients living with
HIV from other patients or implementation of universal pre-
cautions was used in five studies [44,50,59,60,62]. Physicians
and nurses made up the intervention target population of
every study – including students still in training for medicine
and nursing – among which half [44,46,48,49,51,57,59,61-
63,75] also included nonclinical staff such as laboratory techni-
cians or administrative staff in their intervention activities.
Regarding impact, all but one study [47] reported that their
intervention was effective in reducing HIV stigma in health-
care settings. However, in 10 of the studies [44,45,48,55-
59,63,76], the overall conclusion was drawn from selectively








































































































































































































































































































































































































































































































































































Smith MK et al. Journal of the International AIDS Society 2020, 23:e25553
http://onlinelibrary.wiley.com/doi/10.1002/jia2.25553/full | https://doi.org/10.1002/jia2.25553
9
significant effect was observed. In these cases, changes in the
other scale items either lacked statistical significance or in
one case the control condition experienced greater stigma
reduction than the intervention [56].
3.2 | Stigma measurement
As a function of our study inclusion criteria, all interventions
in this review addressed stigma enacted by healthcare provi-
ders in healthcare settings. Yet measures varied widely in
terms of measurement development, the groups surveyed and
the domains assessed (i.e. stigma awareness, HIV knowledge,
value-based judgements and performance). A summary of
measure characteristics is provided in Table 3.
In terms of stigma scale development, about half used
scales or indices developed by the authors themselves in the
course of the study [46,48,50,51,57-59,61,63]. Of these, three
described steps taken to validate the measure, whether by
conducting psychometric analyses of the scales [46,57] or by
pilot-testing questions with local community members [48].
The remainder of studies relied on existing stigma measure-
ment tools which were either used “as is”
[44,45,47,52,55,56,60,75] or with modifications informed by
consultation with local experts [53,62,63] or by pre-testing
the instrument in target communities [49,54].
The most common group surveyed was providers whose
data were used to inform measures of stigma in all but two
studies [50,60]. In nearly all studies where providers were
surveyed [44,46,48,49,51-55,57-59,61-63,75], measures
assessed providers’ responses to questions on factors such as
their degree of comfort treating PLWH, their endorsement of
coercive measures towards PLWH, beliefs regarding PLWH
responsibility for their infection status, or other related items.
The remaining three studies that surveyed providers
approached them as potential witnesses to discriminatory
behaviours taking place in their own workplace using the HIV/
AIDS Stigma Instrument (HASI) [45,47,56]. The next most
common group surveyed were patients who were asked either
as clients evaluating the quality of care received at study clin-
ics [44,60], as witnesses to discriminatory treatment in clinics
[47], or as future patients in term of their willingness to seek
HIV-related care in a study clinic following the intervention
[51]. Each of these four studies utilized patient-related mea-
sures in conjunction with those for providers. In two final
studies, study investigators and staff directly observed provi-
der behaviours to assess evidence of stigma reduction. Allam
et al. [60] observed the persistence of recommended practices
in study clinics such as removing HIV status from patient case
records or integrating hospital wards for inpatients with and
without HIV. Li et al. [50] used an unannounced standardized
patient approach to observe and compare provider behaviours
before and after the intervention.
Regarding stigma domains, the most commonly measured
domain was HIV knowledge [45,46,48,49,51-55,57,58,60-63],
followed by value-based judgements [44,45,48,49,53-
55,58,61-63], stigma awareness [45-47,51,52,54-56,63,75]
and enacted stigma [44,45,47,49-51,56,60]. We were unable
to ascertain the stigma measurement tool used in just one of
the studies [59]. Most studies utilized measures that simulta-
neously captured multiple domains; at most three domains
were measured in the same study [45,54,55].
3.3 | Quality assessment
Appraisal of study quality was restricted to full reports (i.e. all
but the three conference abstracts [58-60]) and conducted
Figure 2. World map indicating locations from which studies included in this review were conducted. Colours indicate the World Bank
income classifications. Note that studies from high-income countries were not included in this review.
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separately depending on whether it was an RCT or quasi-ex-
perimental study. The most common weakness of the three
RCTs included in this review [46,48,75] (Table 2A) was the
lack of blinding of participants or study staff to treatment allo-
cation, an expected result given the nature of behavioural
interventions. Among the 15 quasi-experimental studies
(Table 2B) the most common criteria that studies failed to
meet was inclusion of a control group [44,45,51,52,54,57,62]
and completeness or the reporting of participant follow-up
over time [45,51-53,57,60,63]. Many of the quasi-experimen-
tal studies also lacked adequate detail to inform appraisal by
our reviewers (MKS and RHX), particularly in regards to relia-
bility of the outcome measures. It is worth noting that the Li
et al. [50] study using standardized patients, though classified
here as a quasi-experimental design, was conducted in the
context of a larger RCT that evaluated the intervention using
survey-based stigma outcome measures [90] but was not
included in this review to avoid redundancy.
3.4 | Summary of findings
This scoping review describes a body of rich body of research
by adding 10 new studies to the collective body of research
identified by earlier reviews on this topic [25-28]. This body of
research exhibits some key strengths. First, the 21 studies
included in this review represent LMIC across five of the seven
World Bank regions [38], nine of which were located in or had
at least one site in sub-Saharan Africa [45-48,56,57,59,61,63]
which bears 70% of the global burden of HIV [91]. Regarding
study design over half of the sample used a control condition
[46,49,53,55,56,58,61,63], including three RCTs [46,48,75].
Every intervention in this review employed at least two inter-
vention components, and seven studies utilized stigma mea-
sures that had been developed or modified to account for the
local cultural context. Lastly, all but one [47] of the 21 studies
included in this review reported a significant effect of the inter-
vention in reducing stigma in healthcare settings.
Though the consistency of positive results across these stud-
ies is encouraging, several features of these studies as a group
merit discussion. First, we observed a dearth of studies taking
place within the lowest income category of LMIC, as well as in
Eastern Europe & Central Asia and Latin America & the Carib-
bean, regions where HIV incidence is rising [92,93] or persis-
tent at high levels [94,95]. Second and in terms of interventions,
relatively few (N = 6) sought to address institutional or struc-
tural determinants of stigma [44,50,59,60,62,63]. And although
the fact that many interventions combine multiple components
can be seen as a strength, this can also hinder investigators’
ability to identify the most impactful activities, an insight which
could inform stigma control efforts under budget constraints.
Third, methodological quality across studies varied widely, with
only five studies ranked as “good” [49,50,55,56] and over half
ranked as “poor” [44-46,51,52,54,58-60,62,96]. Lastly, the
homogeneity of the findings that nearly all tested intervention
were effective, while encouraging, may be a byproduct of the
upward bias that can be induced with the use of self-reported
outcomes that trigger social desirability bias. The uniformity of
results also hindered our ability to draw substantive conclusions
about specific best practices to inform future stigma reduction
programmes. Qualitative assessment of the relative magnitudes
of effect may potentially inform a few such insights, though the
one meta-analysis on this topic conducted by Mak et al. cited a
number of challenges to synthesizing findings including the “di-
versity of outcome measures used” [27].
The inherent challenges of stigma measurement are a topic
of longstanding debate [22,42,77,97] and merit special consid-
eration. As a multifaceted phenomenon, stigma measurement
demands complex tools to operationalize its myriad domains.
Yet the tremendous diversity in the measures across the stud-
ies in this review – scale components range from three [75]
to 96 [54] items – undermines our ability draw greater insight
into the state of stigma reduction as a whole. In addition, mea-
surement of some stigma domains – namely HIV knowledge
and stigma awareness – commonly rely on use of hypothetical
questions. This technique tests the underlying assumption that
stigma is driven by ignorance of its effects on its targets or by
fear of accidental transmission. But hypothetical questions are
likely a poor proxy for how respondents behave in real life
[97] and can lead to ambiguous interpretations, particularly in
certain language groups and cultures [98]. Lastly, though
Table 3. Summary of non-self-reported measures of enacted stigma used among a subset of studies included in this scoping review
Measure Description Potential weaknesses
Client satisfaction
survey [44,60]
Patients are surveyed before and after an intervention to
assess their experience with providers and satisfaction
with care
Client satisfaction can be affected by many factors beyond
provider control such as a patient’s baseline health, their




A validated instrument administered to PLWH asking them
to report on personal experiences of stigma such as
verbal abuse or health care neglect
Patient perceptions of medical maltreatment or neglect
may be shaped by asymmetric information regarding the






A validated instrument administered to healthcare
providers asking them to report on instances when
colleagues have stigmatized HIV patients or when they
were stigmatized against for working with HIV patients
Possibility that multiple participants may report on the
same instance of enacted stigma, which could lead to




Trained standardized patients make unannounced clinic
visits to observe behaviours and clinical performance
The need to obtain informed consent from providers prior
to visits could increase risk of less stigmatizing doctors
selecting into the study (selection bias)
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enacted stigma is challenging to measure given low provider
willingness to self-report discriminatory behaviours and their
tendency to alter behaviours under observation [42,99], it can
also provide the most substantive metric to assess whether
stigma reduction interventions achieved their goals. Several
measures of enacted stigma identified in this review side-
stepped the problem of social desirability bias by using tech-
niques other than self-reported measures, whether by asking
providers [45,47,56] and/or patients [44,45,47,60] to bear
witness to enacted stigma, or by deploying standardized
patients to covertly observe provider behaviours [50]. Though
these measures are not without their own limitations – for
example the HASI-N may inadvertently solicit multiple reports
of the same stigma incident – their novelty and potential for
reducing social desirability bias may motivate more research
to further refine and improve techniques like these. A sum-
mary of these techniques and their potential limitations are
provided in Table 3.
4 | CONCLUSIONS
Our findings highlight several important knowledge gaps to
guide future research directions. First, more research is needed
to push the development of objective, reliable and transportable
stigma measures to facilitate more meaningful programme eval-
uation and comparison across studies. Second, a common design
weakness of studies in this review is the inability to blind partici-
pants or study staff to the intervention during the trial (see
Table 2A). The modified Zelen design [100,101] may offer a
partial solution to this problem by not informing control arm
participants of their trial participation until the study end.
Finally, though many incorporated studies address attitudes
towards key populations or HIV-related risk behaviours (e.g.
injection drug use, commercial sex, same sex behaviours), they
do not do so in a systematic way that could distinguish it from
stigma towards HIV infection alone. A way to disentangle the
components that make up intersectional stigma will be neces-
sary in order to address its myriad manifestations.
Nearly 40 years into the epidemic and with wider availabil-
ity of treatment and prevention tools, the persistence of HIV
stigma in healthcare settings remains a matter of great
urgency. Moreover, combating healthcare stigma in LMICs will
require particular attention to the unique combination of
resource constraints, high HIV burden and diverse cultural
contexts that shape stigma [102-108]. More recent proposals
by Hatzenbuehler et al. [109] to regard stigma as a driver of
health inequity may inform a social determinants framework
to mobilize more novel and interdisciplinary approaches to
stigma reduction. By focusing on research conducted in LMIC,
this review highlights research crucial to informing impactful
and sustainable programmes to tackle the underlying drivers
of stigma.
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